358 related articles for article (PubMed ID: 30988284)
21. Comprehensive RNP profiling in cells identifies U1 snRNP complexes with cleavage and polyadenylation factors active in telescripting.
Cai Z; So BR; Dreyfuss G
Methods Enzymol; 2021; 655():325-347. PubMed ID: 34183128
[TBL] [Abstract][Full Text] [Related]
22. Transcription-associated cyclin-dependent kinase 12 (CDK12) as a potential target for cancer therapy.
Wu W; Yu S; Yu X
Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188842. PubMed ID: 36460141
[TBL] [Abstract][Full Text] [Related]
23. CDK12: an emerging therapeutic target for cancer.
Lui GYL; Grandori C; Kemp CJ
J Clin Pathol; 2018 Nov; 71(11):957-962. PubMed ID: 30104286
[TBL] [Abstract][Full Text] [Related]
24. CDK12 phosphorylates 4E-BP1 to enable mTORC1-dependent translation and mitotic genome stability.
Choi SH; Martinez TF; Kim S; Donaldson C; Shokhirev MN; Saghatelian A; Jones KA
Genes Dev; 2019 Apr; 33(7-8):418-435. PubMed ID: 30819820
[TBL] [Abstract][Full Text] [Related]
25.
Warner E; Herberts C; Fu S; Yip S; Wong A; Wang G; Ritch E; Murtha AJ; Vandekerkhove G; Fonseca NM; Angeles A; Beigi A; Schönlau E; Beja K; Annala M; Khalaf D; Chi KN; Wyatt AW
Clin Cancer Res; 2021 Mar; 27(6):1650-1662. PubMed ID: 33414135
[TBL] [Abstract][Full Text] [Related]
26. Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors.
Joshi PM; Sutor SL; Huntoon CJ; Karnitz LM
J Biol Chem; 2014 Mar; 289(13):9247-53. PubMed ID: 24554720
[TBL] [Abstract][Full Text] [Related]
27. CDK12 Is Necessary to Promote Epidermal Differentiation Through Transcription Elongation.
Li J; Tiwari M; Chen Y; Luanpitpong S; Sen GL
Stem Cells; 2022 Apr; 40(4):435-445. PubMed ID: 35325240
[TBL] [Abstract][Full Text] [Related]
28. Suboptimal RNA-RNA interaction limits U1 snRNP inhibition of canonical mRNA 3' processing.
Shi J; Deng Y; Huang S; Huang C; Wang J; Xiang AP; Yao C
RNA Biol; 2019 Oct; 16(10):1448-1460. PubMed ID: 31242075
[TBL] [Abstract][Full Text] [Related]
29. CDK12 regulates co-transcriptional splicing and RNA turnover in human cells.
Magnuson B; Bedi K; Narayanan IV; Bartkowiak B; Blinkiewicz H; Paulsen MT; Greenleaf A; Ljungman M
iScience; 2022 Sep; 25(9):105030. PubMed ID: 36111258
[TBL] [Abstract][Full Text] [Related]
30. CDK12 and Integrator-PP2A complex modulates LEO1 phosphorylation for processive transcription elongation.
Qiu M; Yin Z; Wang H; Lei L; Li C; Cui Y; Dai R; Yang P; Xiang Y; Li Q; Lv J; Hu Z; Chen M; Zhou HB; Fang P; Xiao R; Liang K
Sci Adv; 2023 May; 9(20):eadf8698. PubMed ID: 37205756
[TBL] [Abstract][Full Text] [Related]
31. Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors.
Ito M; Tanaka T; Toita A; Uchiyama N; Kokubo H; Morishita N; Klein MG; Zou H; Murakami M; Kondo M; Sameshima T; Araki S; Endo S; Kawamoto T; Morin GB; Aparicio SA; Nakanishi A; Maezaki H; Imaeda Y
J Med Chem; 2018 Sep; 61(17):7710-7728. PubMed ID: 30067358
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer.
Naidoo K; Wai PT; Maguire SL; Daley F; Haider S; Kriplani D; Campbell J; Mirza H; Grigoriadis A; Tutt A; Moseley PM; Abdel-Fatah TMA; Chan SYT; Madhusudan S; Rhaka EA; Ellis IO; Lord CJ; Yuan Y; Green AR; Natrajan R
Mol Cancer Ther; 2018 Jan; 17(1):306-315. PubMed ID: 29133620
[TBL] [Abstract][Full Text] [Related]
33.
Liang S; Hu L; Wu Z; Chen Z; Liu S; Xu X; Qian A
Cells; 2020 Jun; 9(6):. PubMed ID: 32570740
[TBL] [Abstract][Full Text] [Related]
34. BRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors.
Paculová H; Kramara J; Šimečková Š; Fedr R; Souček K; Hylse O; Paruch K; Svoboda M; Mistrík M; Kohoutek J
Tumour Biol; 2017 Oct; 39(10):1010428317727479. PubMed ID: 29025359
[TBL] [Abstract][Full Text] [Related]
35. Engineering an analog-sensitive CDK12 cell line using CRISPR/Cas.
Bartkowiak B; Yan C; Greenleaf AL
Biochim Biophys Acta; 2015 Sep; 1849(9):1179-87. PubMed ID: 26189575
[TBL] [Abstract][Full Text] [Related]
36. Intronic cleavage and polyadenylation regulates gene expression during DNA damage response through U1 snRNA.
Devany E; Park JY; Murphy MR; Zakusilo G; Baquero J; Zhang X; Hoque M; Tian B; Kleiman FE
Cell Discov; 2016; 2():16013. PubMed ID: 27462460
[TBL] [Abstract][Full Text] [Related]
37. The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma.
Houles T; Boucher J; Lavoie G; MacLeod G; Lin S; Angers S; Roux PP
Cell Death Discov; 2023 Dec; 9(1):459. PubMed ID: 38104154
[TBL] [Abstract][Full Text] [Related]
38. [Function of CDK12 in Tumor initiation and progression and its clinical consequences].
Vrábel D; Svoboda M; Navrátil J; Kohoutek J
Klin Onkol; 2014; 27(5):340-6. PubMed ID: 25312711
[TBL] [Abstract][Full Text] [Related]
39. RNA Polymerase II Transcription Attenuation at the Yeast DNA Repair Gene,
Whalen C; Tuohy C; Tallo T; Kaufman JW; Moore C; Kuehner JN
G3 (Bethesda); 2018 May; 8(6):2043-2058. PubMed ID: 29686108
[TBL] [Abstract][Full Text] [Related]
40. Cyclin-dependent kinase 12 increases 3' end processing of growth factor-induced c-FOS transcripts.
Eifler TT; Shao W; Bartholomeeusen K; Fujinaga K; Jäger S; Johnson JR; Luo Z; Krogan NJ; Peterlin BM
Mol Cell Biol; 2015 Jan; 35(2):468-78. PubMed ID: 25384976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
